CD8A and breast cancer: After neoadjuvant chemotherapy with doxorubicin-containing regimens, BC residual specimens appeared highly infiltrated by T cells (26).Doxorubicin reportedly increases the infiltration of antigen-specific CD8+ lymphocytes in murine mammary gland adenocarcinomas and fibrosarcomas.